A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Takeda
Eli Lilly and Company
Cogent Biosciences, Inc.
Eli Lilly and Company
Kedrion S.p.A.
Ossium Health, Inc.
Orca Biosystems, Inc.
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Pfizer
Novartis
Constellation Pharmaceuticals
Takeda
Kelonia Therapeutics, Inc.
Cogent Biosciences, Inc.
Eli Lilly and Company
Celgene
Novartis
Eli Lilly and Company
Cellenkos, Inc.